i assume the OD will allow the sale of our product so getting some revenue, just some clarity on the path to take would help investors
Ann: Phase II/III autism trial shows further benefits, page-14
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $55.86M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.3¢ | $8.824K | 164.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 2997322 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 263408 | 1 |
View Market Depth
| Last trade - 15.34pm 06/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |